-
Effectiveness of modified vaccinia Ankara-Bavarian Nordic vaccine against mpox infection: emulation of a target trial BMJ (IF 93.6) Pub Date : 2024-09-11 Christine Navarro, Cindy Lau, Sarah A Buchan, Ann N Burchell, Sharifa Nasreen, Lindsay Friedman, Evaezi Okpokoro, Peter C Austin, Darrell H S Tan, Jonathan B Gubbay, Jeffrey C Kwong, Sharmistha Mishra
Objective To estimate the real world effectiveness of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine against mpox infection. Design Emulation of a target trial. Setting Linked databases in Ontario, Canada. Participants 9803 men aged ≥18 years with a history of being tested for syphilis and a laboratory confirmed bacterial sexually transmitted infection (STI) in the previous year, or who
-
Effect of laughter exercise versus 0.1% sodium hyaluronic acid on ocular surface discomfort in dry eye disease: non-inferiority randomised controlled trial BMJ (IF 93.6) Pub Date : 2024-09-11 Jing Li, Yinglin Liao, Shi-Yao Zhang, Ling Jin, Nathan Congdon, Zixin Fan, Yangfa Zeng, Yingfeng Zheng, Zuguo Liu, Yizhi Liu, Lingyi Liang
Objective To assess efficacy and safety of laughter exercise in patients with symptomatic dry eye disease. Design Non-inferiority randomised controlled trial. Setting Recruitment was from clinics and community and the trial took place at Zhongshan Ophthalmic Center, Sun Yat-sen University, the largest ophthalmic centre in China, between 18 June 2020 to 8 January 2021. Participants People with symptomatic
-
Randomised controlled trials on radiation dose fractionation in breast cancer: systematic review and meta-analysis with emphasis on side effects and cosmesis BMJ (IF 93.6) Pub Date : 2024-09-11 Shing Fung Lee, Samantha K F Kennedy, Saverio Caini, Henry C Y Wong, Pui Lam Yip, Philip M Poortmans, Icro Meattini, Orit Kaidar-Person, Abram Recht, Tarek Hijal, Mylin A Torres, Jeffrey Q Cao, Kimberly S Corbin, J Isabelle Choi, Wee Yao Koh, Jennifer Y Y Kwan, Irene Karam, Adrian W Chan, Edward Chow, Gustavo N Marta
Objective To provide a comprehensive assessment of various fractionation schemes in radiation therapy for breast cancer, with a focus on side effects, cosmesis, quality of life, risks of recurrence, and survival outcomes. Design Systematic review and meta-analysis. Data sources Ovid MEDLINE, Embase, and Cochrane Central Register of Controlled Trials (from inception to 23 October 2023). Study selection
-
Measures of how well a vaccine works BMJ (IF 93.6) Pub Date : 2024-09-12 Sharmistha Mishra, Christine Navarro, Jeffrey C Kwong
This article discusses definitions of the effect of vaccines across outcomes of interest, from individual level to contacts of vaccinated people to population level. The focus is on the outcome evaluated in an observational study on the effectiveness of mpox vaccine in the context of potential outcomes that could have been measured. When evaluating how well a vaccine works, two categories of outcomes
-
Prostate cancer incidence and mortality in Europe and implications for screening activities: population based study BMJ (IF 93.6) Pub Date : 2024-09-04 Salvatore Vaccarella, Mengmeng Li, Freddie Bray, Rune Kvale, Diego Serraino, Valentina Lorenzoni, Anssi Auvinen, Luigino Dal Maso
Objective To provide a baseline comparative assessment of the main epidemiological features of prostate cancer in European populations as background for the proposed EU screening initiatives. Design Population based study. Setting 26 European countries, 19 in the EU, 1980-2017. National or subnational incidence data were extracted from population based cancer registries from the International Agency
-
Long term exposure to road traffic noise and air pollution and risk of infertility in men and women: nationwide Danish cohort study BMJ (IF 93.6) Pub Date : 2024-09-04 Mette Sørensen, Aslak Harbo Poulsen, Bugge Nøhr, Jibran Khan, Matthias Ketzel, Jørgen Brandt, Ole Raaschou-Nielsen, Allan Jensen
Objective To investigate associations between long term residential exposure to road traffic noise and particulate matter with a diameter <2.5 µm (PM2.5) and infertility in men and women. Design Nationwide prospective cohort study. Setting Denmark. Participants 526 056 men and 377 850 women aged 30-45 years, with fewer than two children, cohabiting or married, and residing in Denmark between 2000 and
-
Developing clinical prediction models: a step-by-step guide BMJ (IF 93.6) Pub Date : 2024-09-03 Orestis Efthimiou, Michael Seo, Konstantina Chalkou, Thomas Debray, Matthias Egger, Georgia Salanti
Predicting future outcomes of patients is essential to clinical practice, with many prediction models published each year. Empirical evidence suggests that published studies often have severe methodological limitations, which undermine their usefulness. This article presents a step-by-step guide to help researchers develop and evaluate a clinical prediction model. The guide covers best practices in
-
Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes: population based cohort study BMJ (IF 93.6) Pub Date : 2024-08-28 Anna Shin, Bo Kyung Koo, Jun Young Lee, Eun Ha Kang
Objective To compare the risk of dementia associated with sodium-glucose cotransporter-2 (SGLT-2) inhibitors versus dipeptidyl peptidase-4 (DPP-4) inhibitors in adults aged 40-69 years with type 2 diabetes. Design Population based cohort study. Setting Korean National Health Insurance Service data, 2013-21. Participants 110 885 propensity score matched pairs of adults with type 2 diabetes aged 40-69
-
Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis BMJ (IF 93.6) Pub Date : 2024-08-21 Tien-Wei Hsu, Chia-Kuang Tsai, Yu-Chen Kao, Trevor Thompson, Andre F Carvalho, Fu-Chi Yang, Ping-Tao Tseng, Chih-Wei Hsu, Chia-Ling Yu, Yu-Kang Tu, Chih-Sung Liang
Objective To evaluate the comparative effectiveness and acceptability of oral monotherapy using psychedelics and escitalopram in patients with depressive symptoms, considering the potential for overestimated effectiveness due to unsuccessful blinding. Design Systematic review and Bayesian network meta-analysis. Data sources Medline, Cochrane Central Register of Controlled Trials, Embase, PsycINFO,
-
Suicide rates among physicians compared with the general population in studies from 20 countries: gender stratified systematic review and meta-analysis BMJ (IF 93.6) Pub Date : 2024-08-21 Claudia Zimmermann, Susanne Strohmaier, Harald Herkner, Thomas Niederkrotenthaler, Eva Schernhammer
Objectives To estimate age standardised suicide rate ratios in male and female physicians compared with the general population, and to examine heterogeneity across study results. Design Systematic review and meta-analysis. Data sources Studies published between 1960 and 31 March 2024 were retrieved from Embase, Medline, and PsycINFO. There were no language restrictions. Forward and backwards reference
-
Clinical value of guideline recommended molecular targets and genome targeted cancer therapies: cross sectional study BMJ (IF 93.6) Pub Date : 2024-08-20 Ariadna Tibau, Thomas J Hwang, Jerry Avorn, Aaron S Kesselheim
Objective To assess the clinical benefit and actionability of molecular targets for genome targeted cancer drugs recommended for clinical practice by the National Comprehensive Cancer Network (NCCN). Design Cross sectional study. Participants/setting Genome targeted cancer drugs recommended by NCCN guidelines in the advanced setting. Main outcome measures Molecular target actionability was assessed
-
Intake of sugar sweetened beverages among children and adolescents in 185 countries between 1990 and 2018: population based study BMJ (IF 93.6) Pub Date : 2024-08-07 Laura Lara-Castor, Renata Micha, Frederick Cudhea, Victoria Miller, Peilin Shi, Jianyi Zhang, Julia R Sharib, Josh Erndt-Marino, Sean B Cash, Simon Barquera, Dariush Mozaffarian
Objective To quantify global intakes of sugar sweetened beverages (SSBs) and trends over time among children and adolescents. Design Population based study. Setting Global Dietary Database. Population Children and adolescents aged 3-19 years in 185 countries between 1990 and 2018, jointly stratified at subnational level by age, sex, parental education, and rural or urban residence. Results In 2018
-
Decompression alone or with fusion for degenerative lumbar spondylolisthesis (Nordsten-DS): five year follow-up of a randomised, multicentre, non-inferiority trial BMJ (IF 93.6) Pub Date : 2024-08-07 Eric Loratang Kgomotso, Christian Hellum, Morten Wang Fagerland, Tore Solberg, Jens Ivar Brox, Kjersti Storheim, Erland Hermansen, Eric Franssen, Clemens Weber, Helena Brisby, Knut Robert Hector Algaard, Håvard Furunes, Hasan Banitalebi, Inger Ljøstad, Kari Indrekvam, Ivar Magne Austevoll
Objective To assess whether decompression alone is non-inferior to decompression with instrumented fusion five years after primary surgery in patients with degenerative lumbar spondylolisthesis. Design Five year follow-up of a randomised, multicentre, non-inferiority trial (Nordsten-DS). Setting 16 public orthopaedic and neurosurgical clinics in Norway. Participants Patients aged 18-80 years with symptomatic
-
Personal protective effect of wearing surgical face masks in public spaces on self-reported respiratory symptoms in adults: pragmatic randomised superiority trial BMJ (IF 93.6) Pub Date : 2024-07-24 Runar Barstad Solberg, Atle Fretheim, Ingeborg Hess Elgersma, Mette Fagernes, Bjørn Gunnar Iversen, Lars G Hemkens, Christopher James Rose, Petter Elstrøm
Objective To evaluate the personal protective effects of wearing versus not wearing surgical face masks in public spaces on self-reported respiratory symptoms over a 14 day period. Design Pragmatic randomised superiority trial. Setting Norway. Participants 4647 adults aged ≥18 years: 2371 were assigned to the intervention arm and 2276 to the control arm. Interventions Participants in the intervention
-
Estimating the economic effect of harm associated with high risk prescribing of oral non-steroidal anti-inflammatory drugs in England: population based cohort and economic modelling study BMJ (IF 93.6) Pub Date : 2024-07-24 Elizabeth M Camacho, Leonie S Penner, Amy Taylor, Bruce Guthrie, Anthony J Avery, Darren M Ashcroft, Daniel R Morales, Gabriel Rogers, Antony Chuter, Rachel A Elliott
Objectives To quantify prevalence, harms, and NHS costs in England of problematic oral non-steroidal anti-inflammatory drug (NSAID) prescribing in high risk groups. Design Population based cohort and economic modelling study. Setting Economic models estimating patient harm associated with NSAID specific hazardous prescribing events, and cost to the English NHS, over a 10 year period, were combined
-
Intraosseous versus intravenous vascular access in upper extremity among adults with out-of-hospital cardiac arrest: cluster randomised clinical trial (VICTOR trial) BMJ (IF 93.6) Pub Date : 2024-07-23 Ying-Chih Ko, Hao-Yang Lin, Edward Pei-Chuan Huang, An-Fu Lee, Ming-Ju Hsieh, Chih-Wei Yang, Bin-Chou Lee, Yao-Cheng Wang, Wen-Shuo Yang, Yu-Chun Chien, Jen-Tang Sun, Matthew Huei-Ming Ma, Wen-Chu Chiang
Objective To compare the effectiveness of intraosseous versus intravenous vascular access in the treatment of adult patients with out-of-hospital cardiac arrest. Design Cluster randomised controlled trial. Setting The VICTOR (Venous Injection Compared To intraOsseous injection during resuscitation of patients with out-of-hospital cardiac arrest) trial involved emergency medical service agencies with
-
Learning implementation of a guideline based decision support system to improve hypertension treatment in primary care in China: pragmatic cluster randomised controlled trial BMJ (IF 93.6) Pub Date : 2024-07-23 Jiali Song, Xiuling Wang, Bin Wang, Yilan Ge, Lei Bi, Fuyu Jing, Huijun Jin, Teng Li, Bo Gu, Lili Wang, Jun Hao, Yanyan Zhao, Jiamin Liu, Haibo Zhang, Xi Li, Jing Li, Wenjun Ma, Jiguang Wang, Sharon-Lise T Normand, Jeph Herrin, Jane Armitage, Harlan M Krumholz, Xin Zheng
Objective To evaluate the effectiveness of a clinical decision support system (CDSS) in improving the use of guideline accordant antihypertensive treatment in primary care settings in China. Design Pragmatic, open label, cluster randomised trial. Setting 94 primary care practices in four urban regions of China between August 2019 and July 2022: Luoyang (central China), Jining (east China), and Shenzhen
-
Covid-19 infection and vaccination during first trimester and risk of congenital anomalies: Nordic registry based study BMJ (IF 93.6) Pub Date : 2024-07-17 Maria C Magnus, Jonas Söderling, Anne K Örtqvist, Anne-Marie Nybo Andersen, Olof Stephansson, Siri E Håberg, Stine Kjaer Urhoj
Objectives To evaluate the risk of major congenital anomalies according to infection with or vaccination against covid-19 during the first trimester of pregnancy. Design Prospective Nordic registry based study. Setting Sweden, Denmark, and Norway. Participants 343 066 liveborn singleton infants in Sweden, Denmark, and Norway, with an estimated start of pregnancy between 1 March 2020 and 14 February
-
Trends in long term vaping among adults in England, 2013-23: population based study BMJ (IF 93.6) Pub Date : 2024-07-17 Sarah E Jackson, Harry Tattan-Birch, Lion Shahab, Jamie Brown
Objective To examine trends in long term (>6 months) vaping among adults in England. Design Population based study. Setting England. Participants 179 725 adults (≥18 years) surveyed between October 2013 and October 2023. Main outcome measures Time trends in prevalence of long term vaping using logistic regression, overall and by vaping frequency (daily or non-daily), and main type of device used (disposable
-
Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson’s disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial BMJ (IF 93.6) Pub Date : 2024-07-10 Catherine M Sackley, Caroline Rick, Marian C Brady, Rebecca Woolley, Christopher Burton, Smitaa Patel, Patricia Masterson-Algar, Avril Nicoll, Christina H Smith, Sue Jowett, Natalie Ives, Gillian Beaton, Sylvia Dickson, Ryan Ottridge, Leslie Sharp, Helen Nankervis, Carl E Clarke
Objectives To assess the clinical effectiveness of two speech and language therapy approaches versus no speech and language therapy for dysarthria in people with Parkinson’s disease. Design Pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial. Setting The speech and language therapy interventions were delivered in outpatient or home settings between 26
-
Effectiveness of behavioural interventions with motivational interviewing on physical activity outcomes in adults: systematic review and meta-analysis BMJ (IF 93.6) Pub Date : 2024-07-10 SuFen Zhu, Deepra Sinha, Megan Kirk, Moscho Michalopoulou, Anisa Hajizadeh, Gina Wren, Paul Doody, Lucy Mackillop, Ralph Smith, Susan A Jebb, Nerys M Astbury
Objective To evaluate the effectiveness of behavioural interventions that include motivational interviewing on physical activity outcomes in adults. Design Systematic review and meta-analysis. Study selection A search of seven databases for randomised controlled trials published from inception to 1 March 2023 comparing a behavioural intervention including motivational interviewing with a comparator
-
Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based study BMJ (IF 93.6) Pub Date : 2024-06-26 Nathalie Conrad, Geert Molenberghs, Geert Verbeke, Francesco Zaccardi, Claire Lawson, Jocelyn M Friday, Huimin Su, Pardeep S Jhund, Naveed Sattar, Kazem Rahimi, John G Cleland, Kamlesh Khunti, Werner Budts, John J V McMurray
Objective To investigate the incidence of cardiovascular disease (CVD) overall and by age, sex, and socioeconomic status, and its variation over time, in the UK during 2000-19. Design Population based study. Setting UK. Participants 1 650 052 individuals registered with a general practice contributing to Clinical Practice Research Datalink and newly diagnosed with at least one CVD from 1 January 2000
-
SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study BMJ (IF 93.6) Pub Date : 2024-06-26 Edouard L Fu, Deborah J Wexler, Sara J Cromer, Katsiaryna Bykov, Julie M Paik, Elisabetta Patorno
Objectives To evaluate the comparative effectiveness of sodium-glucose cotransporter-2 (SGLT-2) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, and dipeptidyl peptidase-4 (DPP-4) inhibitors in preventing hyperkalemia in people with type 2 diabetes in routine clinical practice. Design Population based cohort study with active-comparator, new user design. Setting Claims data from Medicare
-
Colchicine in patients with acute ischaemic stroke or transient ischaemic attack (CHANCE-3): multicentre, double blind, randomised, placebo controlled trial BMJ (IF 93.6) Pub Date : 2024-06-26 Jiejie Li, Xia Meng, Fu-Dong Shi, Jing Jing, Hong-Qiu Gu, Aoming Jin, Yong Jiang, Hao Li, S Claiborne Johnston, Graeme J Hankey, J Donald Easton, Liguo Chang, Penglai Shi, Lihua Wang, Xianbo Zhuang, Haitao Li, Yingzhuo Zang, Jianling Zhang, Zengqiang Sun, Dongqi Liu, Ying Li, Hongqin Yang, Jinguo Zhao, Weiran Yu, Anxin Wang, Yuesong Pan, Jinxi Lin, Xuewei Xie, Wei-Na Jin, Shuya Li, Siying Niu, Yilong
Objectives To assess the efficacy and safety of colchicine versus placebo on reducing the risk of subsequent stroke after high risk non-cardioembolic ischaemic stroke or transient ischaemic attack within the first three months of symptom onset (CHANCE-3). Design Multicentre, double blind, randomised, placebo controlled trial. Setting 244 hospitals in China between 11 August 2022 and 13 April 2023.
-
Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial BMJ (IF 93.6) Pub Date : 2024-06-19 Guo-Ying Liu, Yan-Fang Ye, Yao-Fei Jiang, Gina Jinna Chen, Wei-Xiong Xia, Yi-Sheng Huang, Tian-Sheng Gao, Yi-Min Liu, Ya-Ting Hou, Jian-Fei Li, Jia-Hao Liu, Nian Lu, Chang-Long Chen, Liang-Ru Ke, Hu Liang, Wei-Xin Bei, Wang-Zhong Li, Shu-Hui Dong, Qin Liu, Changqing Xie, He-Rui Yao, Yan-Qun Xiang
Objective To compare the effectiveness and safety of nab-paclitaxel, cisplatin, and capecitabine (nab-TPC) with gemcitabine and cisplatin as an alternative first line treatment option for recurrent or metastatic nasopharyngeal carcinoma. Design Phase 3, open label, multicentre, randomised trial. Setting Four hospitals located in China between September 2019 and August 2022. Participants Adults (≥18
-
Lateral episiotomy or no episiotomy in vacuum assisted delivery in nulliparous women (EVA): multicentre, open label, randomised controlled trial BMJ (IF 93.6) Pub Date : 2024-06-17 Sandra Bergendahl, Maria Jonsson, Susanne Hesselman, Victoria Ankarcrona, Åsa Leijonhufvud, Anna-Carin Wihlbäck, Tove Wallström, Emmie Rydström, Hanna Friberg, Helena Kopp Kallner, Sophia Brismar Wendel
Objective To assess the effect of lateral episiotomy, compared with no episiotomy, on obstetric anal sphincter injury in nulliparous women requiring vacuum extraction. Design A multicentre, open label, randomised controlled trial. Setting Eight hospitals in Sweden, 2017-23. Participants 717 nulliparous women with a single live fetus of 34 gestational weeks or more, requiring vacuum extraction were
-
Global burden of type 1 diabetes in adults aged 65 years and older, 1990-2019: population based study BMJ (IF 93.6) Pub Date : 2024-06-12 Kaijie Yang, Xue Yang, Chenye Jin, Shuangning Ding, Tingting Liu, Bing Ma, Hao Sun, Jing Zhang, Yongze Li
Objectives To estimate the burden, trends, and inequalities of type 1 diabetes mellitus (T1DM) among older adults at global, regional, and national level from 1990 to 2019. Design Population based study. Population Adults aged ≥65 years from 21 regions and 204 countries and territories (Global Burden of Disease and Risk Factors Study 2019) from 1990 to 2019. Main outcome measures Primary outcomes were
-
Antiplatelet therapy after coronary artery bypass surgery: five year follow-up of randomised DACAB trial BMJ (IF 93.6) Pub Date : 2024-06-11 Yunpeng Zhu, Wei Zhang, Arnaldo Dimagli, Lin Han, Zhaoyun Cheng, Ju Mei, Xin Chen, Xiaowei Wang, Yanzai Zhou, Qing Xue, Junlong Hu, Min Tang, Rui Wang, Yuanyuan Song, Lei Kang, Bjorn Redfors, Mario Gaudino, Qiang Zhao
Objective To assess the effect of different antiplatelet strategies on clinical outcomes after coronary artery bypass grafting. Design Five year follow-up of randomised Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Grafting (DACAB) trial. Setting Six tertiary hospitals in China; enrolment between July 2014 and November 2015; completion of five year follow-up from August 2019
-
Mailed feedback to primary care physicians on antibiotic prescribing for patients aged 65 years and older: pragmatic, factorial randomised controlled trial BMJ (IF 93.6) Pub Date : 2024-06-05 Kevin L Schwartz, Jennifer Shuldiner, Bradley J Langford, Kevin A Brown, Susan E Schultz, Valerie Leung, Nick Daneman, Mina Tadrous, Holly O Witteman, Gary Garber, Jeremy M Grimshaw, Jerome A Leis, Justin Presseau, Michael S Silverman, Monica Taljaard, Tara Gomes, Meagan Lacroix, Jamie Brehaut, Kednapa Thavorn, Sharon Gushue, Lindsay Friedman, Merrick Zwarenstein, Noah Ivers
Objectives To evaluate whether providing family physicians with feedback on their antibiotic prescribing compared with that of their peers reduces antibiotic prescriptions. To also identify effects on antibiotic prescribing from case-mix adjusted feedback reports and messages emphasising antibiotic associated harms. Design Pragmatic, factorial randomised controlled trial. Setting Primary care physicians
-
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial BMJ (IF 93.6) Pub Date : 2024-05-28 Miao-Zhen Qiu, Do-Youn Oh, Ken Kato, Tobias Arkenau, Josep Tabernero, Marcia Cruz Correa, Anastasia V Zimina, Yuxian Bai, Jianhua Shi, Keun-Wook Lee, Jufeng Wang, Elena Poddubskaya, Hongming Pan, Sun Young Rha, Ruixing Zhang, Hidekazu Hirano, David Spigel, Kensei Yamaguchi, Yee Chao, Lucjan Wyrwicz, Umut Disel, Roberto Pazo Cid, Lorenzo Fornaro, Ludovic Evesque, Hongwei Wang, Yaling Xu, Jiang Li, Tao
Objective To evaluate the efficacy and safety of tislelizumab added to chemotherapy as first line (primary) treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma compared with placebo plus chemotherapy. Design Randomised, double blind, placebo controlled, phase 3 study. Setting 146 medical centres across Asia, Europe, and North America, between 13 December 2018 and 28 February
-
Association between exposure to antibiotics during pregnancy or early infancy and risk of autism spectrum disorder, intellectual disorder, language disorder, and epilepsy in children: population based cohort study BMJ (IF 93.6) Pub Date : 2024-05-22 Ahhyung Choi, Hyesung Lee, Han Eol Jeong, Seo-Young Lee, Jun Soo Kwon, Jung Yeol Han, Young June Choe, Ju-Young Shin
Objective To evaluate the association between antibiotic use during pregnancy or early infancy and the risk of neurodevelopmental disorders in children. Design Nationwide population based cohort study and sibling analysis. Setting Korea’s National Health Insurance Service mother-child linked database, 2008-21. Participants All children live born between 2009 and 2020, followed up until 2021 to compare
-
Epidural analgesia during labour and severe maternal morbidity: population based study BMJ (IF 93.6) Pub Date : 2024-05-22 Rachel J Kearns, Aizhan Kyzayeva, Lucy O E Halliday, Deborah A Lawlor, Martin Shaw, Scott M Nelson
Objectives To determine the effect of labour epidural on severe maternal morbidity (SMM) and to explore whether this effect might be greater in women with a medical indication for epidural analgesia during labour, or with preterm labour. Design Population based study. Setting All NHS hospitals in Scotland. Participants 567 216 women in labour at 24+0 to 42+6 weeks’ gestation between 1 January 2007
-
Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational study BMJ (IF 93.6) Pub Date : 2024-05-15 Milena Falcaro, Kate Soldan, Busani Ndlela, Peter Sasieni
Objectives To replicate previous analyses on the effectiveness of the English human papillomavirus (HPV) vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia (CIN3) using 12 additional months of follow-up, and to investigate effectiveness across levels of socioeconomic deprivation. Design Observational study. Setting England, UK. Participants Women aged
-
Clinical and healthcare use outcomes after cessation of long term opioid treatment due to prescriber workforce exit: quasi-experimental difference-in-differences study BMJ (IF 93.6) Pub Date : 2024-05-16 Adrienne H Sabety, Hannah T Neprash, Marema Gaye, Michael L Barnett
Objective To examine the association between prescriber workforce exit, long term opioid treatment discontinuation, and clinical outcomes. Design Quasi-experimental difference-in-differences study Setting 20% sample of US Medicare beneficiaries, 2011-18. Participants People receiving long term opioid treatment whose prescriber stopped providing office based patient care or exited the workforce, as
-
Long acting progestogens versus combined oral contraceptive pill for preventing recurrence of endometriosis related pain: the PRE-EMPT pragmatic, parallel group, open label, randomised controlled trial BMJ (IF 93.6) Pub Date : 2024-05-15 Kevin G Cooper, Siladitya Bhattacharya, Jane P Daniels, Andrew W Horne, T Justin Clark, Ertan Saridogan, Versha Cheed, Danielle Pirie, Melyda Melyda, Mark Monahan, Tracy E Roberts, Emma Cox, Clive Stubbs, Lee J Middleton
Objectives To evaluate the clinical effectiveness of long acting progestogens compared with the combined oral contraceptive pill in preventing recurrence of endometriosis related pain. Design The PRE-EMPT (preventing recurrence of endometriosis) pragmatic, parallel group, open label, randomised controlled trial. Setting 34 UK hospitals. Participants 405 women of reproductive age undergoing conservative
-
Association of ultra-processed food consumption with all cause and cause specific mortality: population based cohort study BMJ (IF 93.6) Pub Date : 2024-05-08 Zhe Fang, Sinara Laurini Rossato, Dong Hang, Neha Khandpur, Kai Wang, Chun-Han Lo, Walter C Willett, Edward L Giovannucci, Mingyang Song
Objective To examine the association of ultra-processed food consumption with all cause mortality and cause specific mortality. Design Population based cohort study. Setting Female registered nurses from 11 US states in the Nurses’ Health Study (1984-2018) and male health professionals from all 50 US states in the Health Professionals Follow-up Study (1986-2018). Participants 74 563 women and 39 501
-
Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data BMJ (IF 93.6) Pub Date : 2024-05-08 Patrick Bidulka, David G Lugo-Palacios, Orlagh Carroll, Stephen O’Neill, Amanda I Adler, Anirban Basu, Richard J Silverwood, Jonathan W Bartlett, Dorothea Nitsch, Paul Charlton, Andrew H Briggs, Liam Smeeth, Ian J Douglas, Kamlesh Khunti, Richard Grieve
Objective To compare the effectiveness of three commonly prescribed oral antidiabetic drugs added to metformin for people with type 2 diabetes mellitus requiring second line treatment in routine clinical practice. Design Cohort study emulating a comparative effectiveness trial (target trial). Setting Linked primary care, hospital, and death data in England, 2015-21. Participants 75 739 adults with
-
Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis BMJ (IF 93.6) Pub Date : 2024-05-01 Athina-Marina Metaxa, Mike Clarke
Objective To determine the efficacy of psilocybin as an antidepressant compared with placebo or non-psychoactive drugs. Design Systematic review and meta-analysis. Data sources Five electronic databases of published literature (Cochrane Central Register of Controlled Trials, Medline, Embase, Science Citation Index and Conference Proceedings Citation Index, and PsycInfo) and four databases of unpublished
-
Reverse total shoulder replacement versus anatomical total shoulder replacement for osteoarthritis: population based cohort study using data from the National Joint Registry and Hospital Episode Statistics for England BMJ (IF 93.6) Pub Date : 2024-04-30 Epaminondas Markos Valsamis, Albert Prats-Uribe, Ian Koblbauer, Sophie Cole, Adrian Sayers, Michael R Whitehouse, Gillian Coward, Gary S Collins, Rafael Pinedo-Villanueva, Daniel Prieto-Alhambra, Jonathan L Rees
Objectives To answer a national research priority by comparing the risk-benefit and costs associated with reverse total shoulder replacement (RTSR) and anatomical total shoulder replacement (TSR) in patients having elective primary shoulder replacement for osteoarthritis. Design Population based cohort study using data from the National Joint Registry and Hospital Episode Statistics for England. Setting
-
Prenatal opioid exposure and subsequent risk of neuropsychiatric disorders in children: nationwide birth cohort study in South Korea BMJ (IF 93.6) Pub Date : 2024-04-24 Jiseung Kang, Hyeon Jin Kim, Tae Kim, Hyeri Lee, Minji Kim, Seung Won Lee, Min Seo Kim, Ai Koyanagi, Lee Smith, Guillaume Fond, Laurent Boyer, Masoud Rahmati, Guillermo F López Sánchez, Elena Dragioti, Samuele Cortese, Jae Il Shin, Dong Keon Yon, Marco Solmi
Objective To investigate the potential association between prenatal opioid exposure and the risk of neuropsychiatric disorders in children. Design Nationwide birth cohort study. Setting From 1 January 2009 to 31 December 2020, birth cohort data of pregnant women in South Korea linked to their liveborn infants from the National Health Insurance Service of South Korea were collected. Participants All
-
Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study BMJ (IF 93.6) Pub Date : 2024-04-25 Nikita Simms-Williams, Nir Treves, Hui Yin, Sally Lu, Oriana Yu, Richeek Pradhan, Christel Renoux, Samy Suissa, Laurent Azoulay
Objective To determine whether the combined use of glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose cotransporter-2 (SGLT-2) inhibitors is associated with a decreased risk of major adverse cardiovascular events and serious renal events compared with either drug class alone among patients with type 2 diabetes, and to assess the effect of the combination on the individual components
-
Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study BMJ (IF 93.6) Pub Date : 2024-04-17 Pearl L H Mok, Matthew J Carr, Bruce Guthrie, Daniel R Morales, Aziz Sheikh, Rachel A Elliott, Elizabeth M Camacho, Tjeerd van Staa, Anthony J Avery, Darren M Ashcroft
Objective To investigate risks of multiple adverse outcomes associated with use of antipsychotics in people with dementia. Design Population based matched cohort study. Setting Linked primary care, hospital and mortality data from Clinical Practice Research Datalink (CPRD), England. Population Adults (≥50 years) with a diagnosis of dementia between 1 January 1998 and 31 May 2018 (n=173 910, 63.0% women)
-
Predicting the risks of kidney failure and death in adults with moderate to severe chronic kidney disease BMJ (IF 93.6) Pub Date : 2024-04-15 Thomas Alexander Gerds, Pietro Ravani
The risk prediction model for kidney failure and death in people with chronic kidney disease (CKD) presented in the linked study is a super learner. A super learner is an algorithm that repeatedly splits the data into training and test sets and then chooses the best performing model from a list of candidate prediction models. This article describes why and how the super learner was implemented in the
-
Predicting the risks of kidney failure and death in adults with moderate to severe chronic kidney disease: multinational, longitudinal, population based, cohort study BMJ (IF 93.6) Pub Date : 2024-04-15 Ping Liu, Simon Sawhney, Uffe Heide-Jørgensen, Robert Ross Quinn, Simon Kok Jensen, Andrew Mclean, Christian Fynbo Christiansen, Thomas Alexander Gerds, Pietro Ravani
Objective To train and test a super learner strategy for risk prediction of kidney failure and mortality in people with incident moderate to severe chronic kidney disease (stage G3b to G4). Design Multinational, longitudinal, population based, cohort study. Settings Linked population health data from Canada (training and temporal testing), and Denmark and Scotland (geographical testing). Participants
-
Efficacy of a single low dose of esketamine after childbirth for mothers with symptoms of prenatal depression: randomised clinical trial BMJ (IF 93.6) Pub Date : 2024-04-10 Shuo Wang, Chun-Mei Deng, Yuan Zeng, Xin-Zhong Chen, Ai-Yuan Li, Shan-Wu Feng, Li-Li Xu, Liang Chen, Hong-Mei Yuan, Han Hu, Tian Yang, Tao Han, Hui-Ying Zhang, Ming Jiang, Xin-Yu Sun, Hui-Ning Guo, Daniel I Sessler, Dong-Xin Wang
Objective To determine whether a single low dose of esketamine administered after childbirth reduces postpartum depression in mothers with prenatal depression. Design Randomised, double blind, placebo controlled trial with two parallel arms. Setting Five tertiary care hospitals in China, 19 June 2020 to 3 August 2022. Participants 364 mothers aged ≥18 years who had at least mild prenatal depression
-
Impact of large scale, multicomponent intervention to reduce proton pump inhibitor overuse in integrated healthcare system: difference-in-difference study BMJ (IF 93.6) Pub Date : 2024-04-11 Jacob E Kurlander, Loren Laine, Hyungjin Myra Kim, Christopher B Roberts, Darcy Saffar, Aimee Myers, Robert Holleman, Yuqing Gao, Michelle Shank, Richard Nelson, Jane Forman, Christian D Helfrich, Sarah L Krein, Sameer D Saini, Yu-Xiao Yang
Objective To determine how a large scale, multicomponent, pharmacy based intervention to reduce proton pump inhibitor (PPI) overuse affected prescribing patterns, healthcare utilization, and clinical outcomes. Design Difference-in-difference study. Setting US Veterans Affairs Healthcare System, in which one regional network implemented the overuse intervention and all 17 others served as controls.
-
Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study BMJ (IF 93.6) Pub Date : 2024-04-10 Björn Pasternak, Viktor Wintzell, Anders Hviid, Björn Eliasson, Soffia Gudbjörnsdottir, Christian Jonasson, Kristian Hveem, Henrik Svanström, Mads Melbye, Peter Ueda
Objective To investigate whether use of glucagon-like peptide 1 (GLP1) receptor agonists is associated with increased risk of thyroid cancer. Design Scandinavian cohort study. Setting Denmark, Norway, and Sweden, 2007-21. Participants Patients who started GLP1 receptor agonist treatment were compared with patients who started dipeptidyl peptidase 4 (DPP4) inhibitor treatment, and in an additional analysis
-
Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study BMJ (IF 93.6) Pub Date : 2024-04-10 Nicklas Vinter, Pia Cordsen, Søren Paaske Johnsen, Laila Staerk, Emelia J Benjamin, Lars Frost, Ludovic Trinquart
Objectives To examine how the lifetime risks of atrial fibrillation and of complications after atrial fibrillation changed over time. Design Danish, nationwide, population based cohort study. Setting Population of Denmark from 1 January 2000 to 31 December 2022. Participants 3.5 million individuals (51.7% women and 48.3% men) who did not have atrial fibrillation at 45 years of age or older were followed
-
Derivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin: cohort study BMJ (IF 93.6) Pub Date : 2024-03-27 Shruti Gupta, Ilya G Glezerman, Jamie S Hirsch, Kevin L Chen, Nishant Devaraj, Sophia L Wells, Robert H Seitter, Sarah A Kaunfer, Arunima M Jose, Shreya P Rao, Jessica L Ortega, Olivia Green-Lingren, Robert Hayden, Pavan K Bendapudi, Donald F Chute, Meghan E Sise, Kenar D Jhaveri, Valda D Page, Matthew H Abramson, Shveta S Motwani, Wenxin Xu, Kartik Sehgal, Kerry L Reynolds, Anip Bansal, Ala Abudayyeh
Objective To develop and externally validate a prediction model for severe cisplatin associated acute kidney injury (CP-AKI). Design Multicenter cohort study. Setting Six geographically diverse major academic cancer centers across the US. Participants Adults (≥18 years) receiving their first dose of intravenous cisplatin, 2006-22. Main outcome measures The primary outcome was CP-AKI, defined as a twofold
-
Delirium and incident dementia in hospital patients in New South Wales, Australia: retrospective cohort study BMJ (IF 93.6) Pub Date : 2024-03-27 Emily H Gordon, David D Ward, Hao Xiong, Shlomo Berkovsky, Ruth E Hubbard
Objectives To determine the strength and nature of the association between delirium and incident dementia in a population of older adult patients without dementia at baseline. Design Retrospective cohort study using large scale hospital administrative data. Setting Public and private hospitals in New South Wales, Australia between July 2001 and March 2020. Participants Data were extracted for 650 590
-
Use of progestogens and the risk of intracranial meningioma: national case-control study BMJ (IF 93.6) Pub Date : 2024-03-27 Noémie Roland, Anke Neumann, Léa Haszard, Lise Duranteau, Sébastien Froelich, Mahmoud Zureik, Alain Weill
Objective To assess the risk of intracranial meningioma associated with the use of selected progestogens. Design National case-control study. Setting French National Health Data System (ie, Système National des Données de Santé ). Participants Of 108 366 women overall, 18 061 women living in France who had intracranial surgery for meningioma between 1 January 2009 and 31 December 2018 (restricted inclusion
-
Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysis BMJ (IF 93.6) Pub Date : 2024-03-20 Bradley D Menz, Nicole M Kuderer, Stephen Bacchi, Natansh D Modi, Benjamin Chin-Yee, Tiancheng Hu, Ceara Rickard, Mark Haseloff, Agnes Vitry, Ross A McKinnon, Ganessan Kichenadasse, Andrew Rowland, Michael J Sorich, Ashley M Hopkins
Objectives To evaluate the effectiveness of safeguards to prevent large language models (LLMs) from being misused to generate health disinformation, and to evaluate the transparency of artificial intelligence (AI) developers regarding their risk mitigation processes against observed vulnerabilities. Design Repeated cross sectional analysis. Setting Publicly accessible LLMs. Methods In a repeated cross
-
Quality and safety of artificial intelligence generated health information BMJ (IF 93.6) Pub Date : 2024-03-20 Michael J Sorich, Bradley D Menz, Ashley M Hopkins
Generative artificial intelligence (AI) is advancing rapidly and has the potential to greatly improve many aspects of society, including health. The risks of potentially harmful consequences, however, necessitate effective oversight and mitigation measures. This article highlights distinct forms of health related risks of generative AI, with corresponding options for mitigating risk. Although artificial
-
Community based complex interventions to sustain independence in older people: systematic review and network meta-analysis BMJ (IF 93.6) Pub Date : 2024-03-21 Thomas F Crocker, Joie Ensor, Natalie Lam, Magda Jordão, Ram Bajpai, Matthew Bond, Anne Forster, Richard D Riley, Deirdre Andre, Caroline Brundle, Alison Ellwood, John Green, Matthew Hale, Lubena Mirza, Jessica Morgan, Ismail Patel, Eleftheria Patetsini, Matthew Prescott, Ridha Ramiz, Oliver Todd, Rebecca Walford, John Gladman, Andrew Clegg
Objective To synthesise evidence of the effectiveness of community based complex interventions, grouped according to their intervention components, to sustain independence for older people. Design Systematic review and network meta-analysis. Data sources Medline, Embase, CINAHL, PsycINFO, CENTRAL, clinicaltrials.gov, and International Clinical Trials Registry Platform from inception to 9 August 2021
-
25 year trends in cancer incidence and mortality among adults aged 35-69 years in the UK, 1993-2018: retrospective secondary analysis BMJ (IF 93.6) Pub Date : 2024-03-13 Jon Shelton, Ewa Zotow, Lesley Smith, Shane A Johnson, Catherine S Thomson, Amar Ahmad, Lars Murdock, Diana Nagarwalla, David Forman
Objective To examine and interpret trends in UK cancer incidence and mortality for all cancers combined and for the most common cancer sites in adults aged 35-69 years. Design Retrospective secondary data analysis. Data sources Cancer registration data, cancer mortality and national population data from the Office for National Statistics, Public Health Wales, Public Health Scotland, Northern Ireland
-
Cervical pessary versus vaginal progesterone in women with a singleton pregnancy, a short cervix, and no history of spontaneous preterm birth at less than 34 weeks’ gestation: open label, multicentre, randomised, controlled trial BMJ (IF 93.6) Pub Date : 2024-03-12 Charlotte E van Dijk, Annabelle L van Gils, Maud D van Zijl, Bouchra Koullali, Marijke C van der Weide, Eline S van den Akker, Brenda J Hermsen, Wilhelmina M van Baal, Henricus Visser, Joris van Drongelen, Karlijn C Vollebregt, Moira Muller, Flip W van der Made, Sanne J Gordijn, Yolanda M de Mooij, Martijn A Oudijk, Marjon A de Boer, Ben WJ Mol, Brenda M Kazemier, Eva Pajkrt
Objective To compare the effectiveness of cervical pessary and vaginal progesterone in the prevention of adverse perinatal outcomes and preterm birth in pregnant women of singletons with no prior spontaneous preterm birth at less than 34 weeks’ gestation and who have a short cervix of 35 mm or less. Design Open label, multicentre, randomised, controlled trial. Setting 20 hospitals and five obstetric
-
Comparison of prior authorization across insurers: cross sectional evidence from Medicare Advantage BMJ (IF 93.6) Pub Date : 2024-03-07 Ravi Gupta, Jay Fein, Joseph P Newhouse, Aaron L Schwartz
Objective To measure and compare the scope of US insurers’ policies for prior authorization (PA), a process by which insurers assess the necessity of planned medical care, and to quantify differences in PA across insurers, physician specialties, and clinical service categories. Design Cross sectional analysis. Setting PA policies for five insurers serving most of the beneficiaries covered by privately
-
Diagnostic accuracy of magnetically guided capsule endoscopy with a detachable string for detecting oesophagogastric varices in adults with cirrhosis: prospective multicentre study BMJ (IF 93.6) Pub Date : 2024-03-05 Xi Jiang, Jun Pan, Qing Xu, Yu-Hu Song, Huan-Huan Sun, Cheng Peng, Xiao-Long Qi, Yang-Yang Qian, Wen-Bin Zou, Yang Yang, Shao-Qin Jin, Ben-Song Duan, Shan Wu, Ye Chu, Ding-Hua Xiao, Li-Juan Hu, Jun-Zhi Cao, Jin-Feng Dai, Xiao Liu, Tian Xia, Wei Zhou, Tao Chen, Chun-Hua Zhou, Wei Wu, Shao-Jun Liu, Zhen-Yu Yang, Fen Wang, Lu Zhang, Cheng-Zhong Li, Hao Xu, Jun-Xue Wang, Bo Wei, Yong Lin, Xing Deng, Li-Hong
Objective To evaluate the diagnostic accuracy and safety of using magnetically guided capsule endoscopy with a detachable string (ds-MCE) for detecting and grading oesophagogastric varices in adults with cirrhosis. Design Prospective multicentre diagnostic accuracy study. Setting 14 medical centres in China. Participants 607 adults (>18 years) with cirrhosis recruited between 7 January 2021 and 25
-
Added benefit and revenues of oncology drugs approved by the European Medicines Agency between 1995 and 2020: retrospective cohort study BMJ (IF 93.6) Pub Date : 2024-02-28 Francine Brinkhuis, Wim G Goettsch, Aukje K Mantel-Teeuwisse, Lourens T Bloem
Objectives To evaluate the added benefit and revenues of oncology drugs, explore their association, and investigate potential discrepancies between added benefit and revenues across different approval pathways of the European Medicines Agency (EMA). Design Retrospective cohort study. Setting Oncology drugs and their indications approved by the EMA between 1995 and 2020. Main outcome measures Added
-
Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses BMJ (IF 93.6) Pub Date : 2024-02-28 Melissa M Lane, Elizabeth Gamage, Shutong Du, Deborah N Ashtree, Amelia J McGuinness, Sarah Gauci, Phillip Baker, Mark Lawrence, Casey M Rebholz, Bernard Srour, Mathilde Touvier, Felice N Jacka, Adrienne O’Neil, Toby Segasby, Wolfgang Marx
Objective To evaluate the existing meta-analytic evidence of associations between exposure to ultra-processed foods, as defined by the Nova food classification system, and adverse health outcomes. Design Systematic umbrella review of existing meta-analyses. Data sources MEDLINE, PsycINFO, Embase, and the Cochrane Database of Systematic Reviews, as well as manual searches of reference lists from 2009